Published June 29, 2010 | Version v1
Patent Open

Recombinant herpes simplex virus useful for treating neoplastic disease

  • 1. University of Alabama at Birmingham
  • 2. University of Chicago

Contributors

Description

Recombinant herpes simplex viruses comprising DNA encoding cytokines and methods for treating neoplastic diseases using the inventive recombinant viruses are disclosed.

Files

US7744899.pdf

Files (891.9 kB)

Name Size Download all
md5:3ff28fc59660cb8f5d4c363fcec532eb
891.9 kB Preview Download

Additional details

Identifiers

Patent number
US 7744899 B2
Patent application number
US 54623306 A
Other
oai:uchicago.tind.io:9540

Dates

Patent filed
2006-10-11

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Microbiology